Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06361303 · ClinicalTrials.gov registry record
The Happiest Baby, Inc. SNOO Postmarket Surveillance Study
A clinical trial of Infant Death and Serious Injury, sponsored by Happiest Baby.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06361303 is a study of Infant Death and Serious Injury that is actively recruiting participants, run by Happiest Baby. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06361303, a study of Infant Death and Serious Injury, is actively recruiting participants, sponsored by Happiest Baby.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.
Conditions Studied
Interventions
- DEVICE SNOO Bassinet
Study Locations (1)
California
- Happiest Baby, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06361303
The ClinicalTrials.gov registry entry for NCT06361303 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Happiest Baby, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Infant Death appearing as the primary indexed condition, and to 1 intervention - of which SNOO Bassinet is the first listed.
NCT06361303 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06361303 about?
NCT06361303 is a clinical study titled "The Happiest Baby, Inc. SNOO Postmarket Surveillance Study". This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurri...
What is the current status of trial NCT06361303?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-11-29. Estimated completion is 2026-05.
What conditions does trial NCT06361303 study?
This clinical trial studies the following conditions: Infant Death, Serious Injury.
What interventions are being tested in trial NCT06361303?
The interventions under investigation include: SNOO Bassinet (DEVICE).
Who is sponsoring clinical trial NCT06361303?
This trial is sponsored by Happiest Baby, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06361303 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant Death
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.